#Africa

Formerly at Oxfam, Winnie Byanyima is the executive director of UNAIDS. She says fighting the epidemic is “very personal.”

The PopART study is one of three that have recently reported findings of such programs in sub-Saharan Africa.

The vaccine in the APPROACH study, which led to the Imbokodo and forthcoming Mosaico trails, prompted a robust immune response.

Poised for regulatory approval, the monthly vaginal ring appeared to lower the risk of HIV by about 39% overall in a recent study.

The program was associated with an impressive rise in viral suppression rates.

Researchers compared outcomes between babies born to HIV-positive mothers exposed to antiretrovirals and those who were not.

In 2015, research led the World Health Organization to recommend treating HIV regardless of CD4 count.

Previous studies had suggested that certain contraception methods increased the risk of contracting the virus.

These countries fall outside of the set of 13 that are prioritized by U.S. foreign aid.

Nearly $200 million of the pledge will go to DREAMS programs in Africa and the Caribbean.

“I have walked this earth, Black, Queer and HIV positive, but no transgression against me has been as powerful as the hope I hold within.”

Harnessing global momentum to achieve progress for children and adolescents affected by HIV.

Researchers conducted a systematic review of 60 studies in search of answers.

William Matovu, an activist from Uganda, describes the impact of learning U=U and his advocacy as a part of the Love to Love Organisation

Looking only at national prevalence masks hot spots where resources to combat the epidemic are most needed.

A machine learning algorithm designed small sets of proteins that boasted the greatest potential to elicit a broad-based immune response.